The evidence that CD8+/CD16+/CD56- patients were characterized by higher level of Fas ligand, as a consequence of their higher STAT3 phosphorylation, offers a mechanistic explanation for the correlation between STAT3 activation and neutropenia. The gene discussed is STAT3; the disease is neutropenia.